Home › Immune System and Disorders › North Dakota › Fargo
Immune System and Disorders clinical trials in Fargo, ND
3 studies for Immune System and Disorders are looking for participants at sites in and around Fargo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
RecruitingPhase 3
- Red River Research Partners LLC, Fargo
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RecruitingObservational study
- Sanford South University Medical Center, Fargo
- Southpointe-Sanford Medical Center Fargo, Fargo
- Sanford Medical Center Fargo, Fargo
- and 2 more
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Inmagene Site 10, Fargo
About Immune System and Disorders
Your immune system is made up of cells, tissues, and organs that fight infections and diseases. Learn how it works, and about diseases of the immune system.
More about Immune System and Disorders on MedlinePlus
Immune System and Disorders trials in other cities
- Washington, DC13 studies
- New York City, NY12 studies
- Boston, MA10 studies
- Portland, OR10 studies
- Atlanta, GA10 studies
- Philadelphia, PA10 studies
- Houston, TX9 studies
- Los Angeles, CA9 studies
- Cleveland, OH8 studies
- Chicago, IL8 studies
- Seattle, WA6 studies
- Milwaukee, WI6 studies
Other studies in Fargo
- Non-Small Cell Lung Cancer15 studies
- Lung Cancer13 studies
- Cancer (all types)10 studies
- Obesity9 studies
- Melanoma9 studies
- Prostate Cancer8 studies
- Overweight8 studies
- Breast Cancer7 studies
- Acute Myeloid Leukemia7 studies
- Colorectal Cancer7 studies
- Ovarian Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.